SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-211060
Filing Date
2008-10-15
Accepted
2008-10-15 17:08:50
Documents
8
Period of Report
2008-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21482
2 AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER dex21.htm EX-2.1 63864
3 PRESS RELEASE, DATED OCTOBER 15, 2008 dex991.htm EX-99.1 19767
4 SUPPLEMENT NO. 1, DATED OCTOBER 15, 2008 dex992.htm EX-99.2 212562
5 GRAPHIC g44398g11b26.jpg GRAPHIC 16171
6 GRAPHIC g44398g36t25.jpg GRAPHIC 6259
7 GRAPHIC g44398g39m42.jpg GRAPHIC 22208
8 GRAPHIC g44398g56j65.jpg GRAPHIC 3887
  Complete submission text file 0001193125-08-211060.txt   386658
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25317 | Film No.: 081125686
SIC: 2836 Biological Products, (No Diagnostic Substances)